Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Matthias Paprotny"'
Autor:
Matthias Paprotny, Frank Ruschitzka, Bernd Lüders, Markus J. Wilhelm, Raed Aser, Dominique Bettex, Andreas J. Flammer, Alain Rudiger, Stephan Winnik
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 14, Iss 1, Pp 1-4 (2019)
Abstract Background Left ventricular assist devices (LVAD) have become a common treatment option in advanced heart failure. Lack of aortic valve opening during left ventricular unloading is a common complication and associated with a worse outcome. M
Externí odkaz:
https://doaj.org/article/6ebc3c6c9a3748e1bc44cd50d988798b
Autor:
Sarah L. Thiel, Myriam C. Weber, Lorenz Risch, Nadia Wohlwend, Thomas Lung, Dorothea Hillmann, Michael Ritzler, Martin Risch, Philipp Kohler, Pietro Vernazza, Christian R Kahlert, Felix Fleisch, Alexia Cusini, Tomas V. Karajan, Sandra Copeland, Matthias Paprotny
Publikováno v:
Swiss Medical Weekly, Vol 150, Iss 4142 (2020)
BACKGROUND The principality of Liechtenstein had its first COVID-19 case at the beginning of March 2020. After exponential growth, the pandemic’s first wave was contained, with the last case being diagnosed 52 days after the initial occurrence.
Externí odkaz:
https://doaj.org/article/56dddb101fb340d68a19c512959efd33
Autor:
Marc Kovac, Lorenz Risch, Sarah Thiel, Myriam Weber, Kirsten Grossmann, Nadja Wohlwend, Thomas Lung, Dorothea Hillmann, Michael Ritzler, Susanna Bigler, Francesca Ferrara, Thomas Bodmer, Konrad Egli, Mauro Imperiali, Sonja Heer, Yacir Salimi, Harald Renz, Philipp Kohler, Pietro Vernazza, Christian R. Kahlert, Matthias Paprotny, Martin Risch
Publikováno v:
Diagnostics, Vol 10, Iss 8, p 593 (2020)
While lateral flow test formats can be utilized with whole blood and low sample volumes, their diagnostic characteristics are inferior to immunoassays based on chemiluminescence immunoassay (CLIA) or enzyme-linked immunosorbent assay (ELISA) technolo
Externí odkaz:
https://doaj.org/article/31ceebf5922545db85d2107ee2c84c4a
Autor:
Michael Ritzler, Sarah Thiel, Matthias Paprotny, Thomas Bodmer, Kirsten Grossmann, Alexia Cusini, Francesca Ferrara, Christian R Kahlert, Sonja Heer, Nadia Wohlwend, Harald Renz, Myriam Weber, Thomas Lung, Felix Fleisch, Lorenz Risch, Konrad Egli, Dorothea Hillmann, Mauro Imperiali, Susanna Bigler, Martin Risch, Yacir Salimi, Pietro Vernazza, Susanne Nigg, Philipp Kohler
Publikováno v:
Disease Markers
Disease Markers, Vol 2021 (2021)
Weber, Myriam C; Risch, Martin; Thiel, Sarah L; Grossmann, Kirsten; Nigg, Susanne; Wohlwend, Nadia; Lung, Thomas; Hillmann, Dorothea; Ritzler, Michael; Ferrara, Francesca; Bigler, Susanna; Egli, Konrad; Bodmer, Thomas; Imperiali, Mauro; Salimi, Yacir; Fleisch, Felix; Cusini, Alexia; Heer, Sonja; Renz, Harald; Paprotny, Matthias; ... (2021). Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies. Disease markers, 2021, p. 8810196. Hindawi 10.1155/2021/8810196
Disease Markers, Vol 2021 (2021)
Weber, Myriam C; Risch, Martin; Thiel, Sarah L; Grossmann, Kirsten; Nigg, Susanne; Wohlwend, Nadia; Lung, Thomas; Hillmann, Dorothea; Ritzler, Michael; Ferrara, Francesca; Bigler, Susanna; Egli, Konrad; Bodmer, Thomas; Imperiali, Mauro; Salimi, Yacir; Fleisch, Felix; Cusini, Alexia; Heer, Sonja; Renz, Harald; Paprotny, Matthias; ... (2021). Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies. Disease markers, 2021, p. 8810196. Hindawi 10.1155/2021/8810196
Several tests based on chemiluminescence immunoassay techniques have become available to test for SARS-CoV-2 antibodies. There is currently insufficient data on serology assay performance beyond 35 days after symptoms onset. We aimed to evaluate SARS
Autor:
Harald Renz, Stefanie Aeschbacher, Corina Risch, Martin Risch, Kirsten Grossmann, Thomas Bodmer, Michael Pichler, David Conen, Lorenz Risch, Raphael Twerenbold, Dorothea Hillmann, Pietro Vernazza, Mauro Imperiali, Anna Schaffner, Nadia Wohlwend, Susanna Bigler, Katharina Jüngert, Philipp Kohler, Matthias Paprotny, Myriam Weber, Thomas Lung, Christian R Kahlert, Sarah Thiel
Publikováno v:
Journal of Clinical Medicine
Volume 9
Issue 12
Schaffner, Anna; Risch, Lorenz; Aeschbacher, Stefanie; Risch, Corina; Weber, Myriam C; Thiel, Sarah L; Jüngert, Katharina; Pichler, Michael; Grossmann, Kirsten; Wohlwend, Nadia; Lung, Thomas; Hillmann, Dorothea; Bigler, Susanna; Bodmer, Thomas; Imperiali, Mauro; Renz, Harald; Kohler, Philipp; Vernazza, Pietro; Kahlert, Christian R; Twerenbold, Raphael; ... (2020). Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study. Journal of clinical medicine, 9(12) MDPI 10.3390/jcm9123989
Journal of Clinical Medicine, Vol 9, Iss 3989, p 3989 (2020)
Volume 9
Issue 12
Schaffner, Anna; Risch, Lorenz; Aeschbacher, Stefanie; Risch, Corina; Weber, Myriam C; Thiel, Sarah L; Jüngert, Katharina; Pichler, Michael; Grossmann, Kirsten; Wohlwend, Nadia; Lung, Thomas; Hillmann, Dorothea; Bigler, Susanna; Bodmer, Thomas; Imperiali, Mauro; Renz, Harald; Kohler, Philipp; Vernazza, Pietro; Kahlert, Christian R; Twerenbold, Raphael; ... (2020). Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study. Journal of clinical medicine, 9(12) MDPI 10.3390/jcm9123989
Journal of Clinical Medicine, Vol 9, Iss 3989, p 3989 (2020)
Pan-immunoglobulin assays can simultaneously detect IgG, IgM and IgA directed against the receptor binding domain (RBD) of the S1 subunit of the spike protein (S) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 S1-RBD Ig). In this work
Autor:
Pietro Vernazza, Sarah Thiel, Philipp Kohler, Michael Ritzler, Tomas V Karajan, Nadia Wohlwend, Matthias Paprotny, Felix Fleisch, Martin Risch, Dorothea Hillmann, Alexia Cusini, Lorenz Risch, Myriam Weber, Thomas Lung, Sandra Copeland, Christian R Kahlert
Publikováno v:
Thiel, Sarah Lucia; Weber, Myriam Carol; Risch, Lorenz; Wohlwend, Nadia; Lung, Thomas; Hillmann, Dorothea; Ritzler, Michael; Risch, Martin; Kohler, Philipp; Vernazza, Pietro; Kahlert, Christian R; Fleisch, Felix; Cusini, Alexia; Karajan, Tomas V; Copeland, Sandra; Paprotny, Matthias (2020). Flattening the curve in 52 days: characterisation of the COVID-19 pandemic in the Principality of Liechtenstein-an observational study. Swiss medical weekly, 150(w20361), w20361. EMH Media 10.4414/smw.2020.20361
BACKGROUND The principality of Liechtenstein had its first COVID-19 case at the beginning of March 2020. After exponential growth, the pandemic’s first wave was contained, with the last case being diagnosed 52 days after the initial occurrence. AIM
Autor:
Pietro Vernazza, Francesca Ferrara, Thomas Bodmer, Alexia Cusini, Myriam Weber, Konrad Egli, Matthias Paprotny, Yacir Salimi, Christian R Kahlert, Harald Renz, Sarah Thiel, Philipp Kohler, Lorenz Risch, Martin Risch, Nadia Wohlwend, Kirsten Grossmann, Michael Ritzler, Thomas Lung, Dorothea Hillmann, Susanna Bigler, Felix Fleisch, Mauro Imperiali
Publikováno v:
BioMed Research International, Vol 2020 (2020)
Risch, Martin; Weber, Myriam; Thiel, Sarah; Grossmann, Kirsten; Wohlwend, Nadia; Lung, Thomas; Hillmann, Dorothea; Ritzler, Michael; Ferrara, Francesca; Bigler, Susanna; Egli, Konrad; Bodmer, Thomas; Imperiali, Mauro; Salimi, Yacir; Fleisch, Felix; Cusini, Alexia; Renz, Harald; Kohler, Philipp; Vernazza, Pietro; Kahlert, Christian R; ... (2020). Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation. BioMed research international, 2020, p. 9878453. Hindawi Publishing Corporation 10.1155/2020/9878453
BioMed Research International
Risch, Martin; Weber, Myriam; Thiel, Sarah; Grossmann, Kirsten; Wohlwend, Nadia; Lung, Thomas; Hillmann, Dorothea; Ritzler, Michael; Ferrara, Francesca; Bigler, Susanna; Egli, Konrad; Bodmer, Thomas; Imperiali, Mauro; Salimi, Yacir; Fleisch, Felix; Cusini, Alexia; Renz, Harald; Kohler, Philipp; Vernazza, Pietro; Kahlert, Christian R; ... (2020). Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation. BioMed research international, 2020, p. 9878453. Hindawi Publishing Corporation 10.1155/2020/9878453
BioMed Research International
Knowledge of the sensitivities of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody tests beyond 35 days after the clinical onset of COVID-19 is insufficient. We aimed to describe positivity rate of SARS-CoV-2 assays employing thr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55538812170dac077854a2055ddb300d
https://doi.org/10.1101/2020.10.17.20214445
https://doi.org/10.1101/2020.10.17.20214445
Autor:
Alexandra Popa, David Bomze, Sarah Thiel, Philipp K Bühler, Josef M. Penninger, Reto Schüpbach, Silvio D. Brugger, Omar Ali, Andreas Bergthaler, Lorenz Risch, Matthias Paprotny, Pietro Vernazza, Lukas Flatz, Myriam Weber, Werner C. Albrich, Christian R Kahlert, Lukas Kern, Alejandro Gómez-Mejia, Philipp Kohler
Publikováno v:
Clinical Infectious Diseases
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
BackgroundWhile the pathogenesis of coronavirus disease 2019 (COVID-19) is becoming increasingly clear, there is little data on IgA response, the first line of bronchial immune defense.ObjectiveTo determine, whether COVID-19 is associated with a vigo
Autor:
Michael Pichler, Harald Renz, Lorenz Risch, Nadia Wohlwend, Anna Schaffner, Myriam Weber, Thomas Lung, Matthias Paprotny, Michael Ritzler, Sandra Copeland, Katharina Jüngert, Martin Risch, Sarah Thiel, Dorothea Hillmann
Publikováno v:
Clinical chemistry and laboratory medicineReferences. 59(2)
Autor:
Pietro Vernazza, Sarah Thiel, Francesca Ferrara, Dorothea Hillmann, Susanna Bigler, Lorenz Risch, Konrad Egli, Martin Risch, Nadja Wohlwend, Michael Ritzler, Matthias Paprotny, Marc Kovac, Thomas Bodmer, Christian R Kahlert, Thomas Lung, Mauro Imperiali, Myriam Weber, Kirsten Grossmann, Philipp Kohler, Sonja Heer, Harald Renz, Yacir Salimi
Publikováno v:
Diagnostics, Vol 10, Iss 593, p 593 (2020)
Diagnostics
Volume 10
Issue 8
Diagnostics
Volume 10
Issue 8
While lateral flow test formats can be utilized with whole blood and low sample volumes, their diagnostic characteristics are inferior to immunoassays based on chemiluminescence immunoassay (CLIA) or enzyme-linked immunosorbent assay (ELISA) technolo